Tiziana Life Sciences (TLSA) Cash & Current Investments (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Cash & Current Investments for 9 consecutive years, with $4.0 million the latest figure, recorded in Q4 2025.

• Quarterly Cash & Current Investments rose 7.68% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (up 7.68% YoY) and the FY2025 annual result came in at $4.0 million, up 7.68% from the prior year.
• Cash & Current Investments declined to $4.0 million in Q4 2025 per TLSA's latest filing, from $7.3 million in the prior quarter.
• Over the last five years, Cash & Current Investments for TLSA reached as high as $54.0 million in Q2 2021 and fell as low as -$455000.0 in Q2 2024.
• A 5-year average of $16.4 million and a median of $7.0 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 106.81% — and 2025, when it jumped 1693.63%.
• Year by year, Cash & Current Investments stood at $42.2 million in 2021, then sank by 54.98% to $19.0 million in 2022, then sank by 95.89% to $781000.0 in 2023, then surged by 376.82% to $3.7 million in 2024, then advanced by 7.68% to $4.0 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $4.0 million, $7.3 million, and $3.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.